Entry Detail



General Information

Database ID:exR0077504
RNA Name:NCL
RNA Type:mRNA
Chromosome:chr2
Starnd:-
Coordinate:
Start Site(bp):231453531End Site(bp):231483641
External Links:ENSG00000115053



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC005258.1
chr19
2269525
2341172
+
ADCYAP1R1
chr7
31052461
31111479
+
AKR1B1
chr7
134442356
134459284
-
AC027796.3
chr17
3585149
3636249
-
AGPAT1
chr6
32168212
32178096
-
AC006064.6
chr12
6556886
6607367
-
AL136295.5
chr14
24147548
24166452
+
ACACA
chr17
37084992
37406836
-
AC093525.2
chr16
2496032
2520218
+
ABHD12
chr20
25294742
25390835
-
ADPRH
chr3
119579268
119589945
+
AC018523.2
chr11
14493783
14520344
-
AGPAT5
chr8
6708642
6761503
+
AKAP8
chr19
15353385
15379798
-
AC245033.1
chr15
82536788
82573194
-
ABCD1
chrX
153724856
153744755
+
ABCF1
chr6
30571393
30597179
+
AFF4
chr5
132875395
132963634
-
AFAP1
chr4
7758714
7939926
-
AFTPH
chr2
64524305
64593005
+
ALDOA
chr16
30064164
30070457
+
AC013394.1
chr15
92883413
92949230
+
ACTG1
chr17
81509971
81523847
-
ADGRG6
chr6
142301854
142446266
+
ACKR3
chr2
236567787
236582354
+
ADAR
chr1
154582057
154628013
-
AC023055.1
chr12
55757275
55827546
-
AHCY
chr20
34280268
34311802
-
AC009690.1
chr15
72284727
72375981
-
ACAP1
chr17
7336529
7351477
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC007780.1
chr17
68413623
68524949
+
AC016876.2
chr17
7581964
7584086
-
AC020663.1
chr16
4730115
4752565
-
AC023509.1
chr12
53441741
53467528
+
AC023908.3
chr15
39782571
39785617
+
AC026461.1
chr16
56682470
56687807
+
AC064802.1
chr8
114282067
114295839
+
AC092143.2
chr16
89919827
89922662
-
AC106864.1
chr4
112693047
112706810
-
AC245033.4
chr15
82533175
82540008
-
AL034346.1
chr6
1383790
1385066
-
AL137129.1
chr14
61734138
61776260
+
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA